Scale-up of an ELEVECTA™ transient rAAV production process in the Xcellerex™ X-platform single-use bioreactor

  • <<
  • >>

BlueskyReddit

Are you looking to achieve scalable, high-titer manufacturing of high-quality rAAV products? Achieve your goal with the next-generation Xcellerex X-platform single-use bioreactor used in tandem with the ELEVECTA transient cell line and optimized, GMP-grade HyClone™ prime expression medium. This tested combination will take you from R&D through to commercial manufacturing. 

Access Now

    Please fill out the information below to access the selected content. If you are already registered, and this information will be filled out for you.
  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • By submitting this form, you consent to Cell & Gene Therapy Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.